Neoadjuvant chemotherapy for bladder cancer

Randall Millikan; Arlene Siefker-Radtke; H. Barton Grossman

doi:10.1016/S1078-1439(03)00148-0

Neoadjuvant chemotherapy for bladder cancer

Randall Millikan
, Arlene Siefker-Radtke
, H. Barton Grossman

Genitourinary Medical Oncology

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

While it is now clear that chemotherapy can contribute to improved outcome for some patients with muscle invasive bladder cancer, selection criteria for this very heterogenous disease are lacking. The authors make an appeal for a biologically (in contrast to anatomically) based staging system, and urge that perioperative chemotherapy be given with standard combinations with curative intent.

Original language	English (US)
Pages (from-to)	464-467
Number of pages	4
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	21
Issue number	6
DOIs	https://doi.org/10.1016/S1078-1439(03)00148-0
State	Published - Nov 2003

Keywords

Bladder cancer
Cystectomy
Neoadjuvant
Staging

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/S1078-1439(03)00148-0

Cite this

@article{6e249706e5fc423f9cee09296a3709df,

title = "Neoadjuvant chemotherapy for bladder cancer",

abstract = "While it is now clear that chemotherapy can contribute to improved outcome for some patients with muscle invasive bladder cancer, selection criteria for this very heterogenous disease are lacking. The authors make an appeal for a biologically (in contrast to anatomically) based staging system, and urge that perioperative chemotherapy be given with standard combinations with curative intent.",

keywords = "Bladder cancer, Cystectomy, Neoadjuvant, Staging",

author = "Randall Millikan and Arlene Siefker-Radtke and Grossman, \{H. Barton\}",

year = "2003",

month = nov,

doi = "10.1016/S1078-1439(03)00148-0",

language = "English (US)",

volume = "21",

pages = "464--467",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy for bladder cancer

AU - Millikan, Randall

AU - Siefker-Radtke, Arlene

AU - Grossman, H. Barton

PY - 2003/11

Y1 - 2003/11

N2 - While it is now clear that chemotherapy can contribute to improved outcome for some patients with muscle invasive bladder cancer, selection criteria for this very heterogenous disease are lacking. The authors make an appeal for a biologically (in contrast to anatomically) based staging system, and urge that perioperative chemotherapy be given with standard combinations with curative intent.

AB - While it is now clear that chemotherapy can contribute to improved outcome for some patients with muscle invasive bladder cancer, selection criteria for this very heterogenous disease are lacking. The authors make an appeal for a biologically (in contrast to anatomically) based staging system, and urge that perioperative chemotherapy be given with standard combinations with curative intent.

KW - Bladder cancer

KW - Cystectomy

KW - Neoadjuvant

KW - Staging

UR - https://www.scopus.com/pages/publications/2142822814

UR - https://www.scopus.com/pages/publications/2142822814#tab=citedBy

U2 - 10.1016/S1078-1439(03)00148-0

DO - 10.1016/S1078-1439(03)00148-0

M3 - Article

C2 - 14693274

AN - SCOPUS:2142822814

SN - 1078-1439

VL - 21

SP - 464

EP - 467

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 6

ER -

Neoadjuvant chemotherapy for bladder cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this